Skip to content

    Rallis India Limited

    RALLIS
    Chemicals·21 Jan 2026
    Management Summary

    Rallis India Limited reported a robust 19% YoY revenue growth in Q3 FY26, reaching ₹623 crores, driven by strong performances in its Seeds and Exports segments. However, PAT saw an 81% decline to ₹2 crores, impacted by a significant one-time gratuity provision. The domestic agrochemical market continues to face challenges from weak demand and limited pricing power, while the company focuses on new product launches, digital initiatives, and strategic partnerships to drive future growth.

    Highlights

    5
    • Q3 FY26 Revenue stood at ₹623 crores, marking a 19% YoY growth from ₹522 crores in Q3 FY25.

    • Overall EBITDA for Q3 FY26 increased by 29% compared to the previous year, reaching ₹58 crores.

    • The Seeds business demonstrated strong growth of 46% YoY, with revenue increasing to ₹43 crores from ₹30 crores in Q3 FY25, driven by paddy, mustard, and wheat.

    • Exports (B2B) topline grew significantly by 73% to ₹129 crores, supported by volume growth, customer base expansion, and improved capacity utilization.

    • The company launched 9 new products in 9M FY26, including 7 Herbicides and 2 Fungicides, and introduced a new biologicals platform 'NuCode'.

    Concerns

    3
    • Profit after tax (PAT) for Q3 FY26 was ₹2 crores, an 81% decline from ₹11 crores in Q3 FY25, primarily due to an exceptional gratuity provision of ₹40 crores.

    • Domestic agrochemical demand remains weak due to stressed demand drivers such as weather issues and low crop prices, leading to industry-wide volume decline.

    • Pricing power remains limited due to intensifying global competition, with China continuing as a primary supplier, capping realizations and potentially compressing margins from rapid technical resets.

    Key financials

    Metrics

    6

    Periods

    2

    Q3 FY26

    5
    • Revenue
      ₹623 Cr
      YoY+19%
    • EBITDA
      ₹58 Cr
      YoY+29.0%
    • PAT
      ₹2 Cr
      YoY-81%
    • Overall Volume Growth
      28.0%
    • Overall Pricing De-growth
      -8%

    9M FY26

    1
    • Revenue
      ₹2,441 Cr
      YoY+9%

    Segment breakdown

    Crop Care (9M FY26)
    ₹1,991 Cr35.0%
    B2C (9M FY26)
    ₹1,401 Cr24.6%
    B2B (9M FY26)
    ₹590 Cr10.4%
    Crop Care (Q3 FY26)
    ₹580 Cr10.2%
    Seeds (9M FY26)
    ₹450 Cr7.9%
    Domestic (B2C) (Q3 FY26)
    ₹391 Cr6.9%
    Exports (B2B) (Q3 FY26)
    ₹129 Cr2.3%
    Soil & Plant Health (Q3 FY26)
    ₹73 Cr1.3%
    CSM (Q3 FY26)
    ₹46 Cr0.8%
    Seeds (Q3 FY26)
    ₹43 Cr0.8%
    Treemap· Share of Revenue

    Capital allocation

    1
    high confidence
    CategoryHeadline
    Liquidity

    Cash ₹455 crores

    Healthy cash and liquid balance as of 31st December.

    Guidance & targets

    6
    CategoryTargetPriority
    Sector Growth
    Agrochemical Sector Growth
    3-4%
    High
    Sector Growth
    Seeds Category CAGR
    5-10%
    High
    Exports Growth
    Indian Agrochemical Exports Growth
    5-6%
    High
    Revenue
    Seeds Business Revenue
    ₹1,000 crores
    Medium
    Revenue
    Soil and Plant Health Business Revenue
    ₹700-800 crores
    Medium
    Profitability
    Overall Blended EBITDA Margin
    500 basis points expansion
    Medium

    What to watch in Q4 FY26

    5

    Impact of Chinese VAT rebate discontinuation

    Next quarter (post-April implementation)
    CurrentApplicable from April 2026
    TargetSpecific details on impact on landed costs, supply, and pricing

    Why it matters

    Could significantly alter cost structures and competitive landscape for technicals, impacting profitability.

    I think this rebate thing is a new, which is applicable from April. So we have to understand... So I think you'll have to wait for some more information to filter in as I know it is applicable only from April.

    Risks & concerns

    5
    RiskSeverity

    Weak Domestic Agrochemical Demand

    Agrochemical demand remains weak due to stressed demand drivers (weather issues, low crop prices), leading to industry-wide volume decline.Management acknowledged

    high

    Limited Pricing Power & Competition

    Pricing power stays limited as global competition intensifies with China continuing as the primary supplier, capping realizations.Management acknowledged

    medium

    Inventory Compression Risk from Technical Resets

    Rapid resets in key technicals (glyphosate/glufosinate/paraquat) can reprice on-hand inventory and compress margins.Management acknowledged

    medium

    Global Reliance on China & Policy Shifts

    Global reliance on China for key technicals (glyphosate, glufosinate, atrazine) exposes costs to tariff and policy shifts, such as the upcoming VAT rebate changes.Management acknowledged

    high

    Uncertainty in International Business Environment

    Unseasonal October rains, higher-than-normal crop damage, new announcements from China, and geopolitical context create uncertainty for international business.Management acknowledged

    medium

    Q&A highlights

    8

    “I think this rebate thing is a new, which is applicable from April. So we have to understand. I certainly believe when they remove the incentive by the month of April, how much they would have already supplied and have they supplied enough to cater to the market... it should lead to some price increase and some consolidation in players.”

    Analyst inquired about a significant upcoming regulatory change in China that could impact raw material costs and global competition, to which management provided an initial assessment.

    asked by Arjun Khanna

    2 min read5 chapters

    Detailed Narrative

    01

    Q3 FY26 Performance Highlights and Challenges

    Rallis India Limited reported a Q3 FY26 revenue of ₹623 crores, marking a 19% year-on-year growth. This was accompanied by a 28% volume growth, though offset by an 8% pricing de-growth. EBITDA for the quarter increased by 29% to ₹58 crores. However, profit after tax (PAT) saw a significant decline of 81% to ₹2 crores, primarily due to an exceptional gratuity provision of ₹40 crores related to wage code implementation. For the nine-month period, topline revenue grew 9% to ₹2441 crores.

    02

    Domestic Agrochemical Market Dynamics

    The domestic agrochemical market continues to face headwinds, with demand remaining weak due to stressed drivers such as adverse weather conditions and low crop prices, leading to an industry-wide volume decline. Farmer interest in high-value products has dropped. While South & West India experienced sharp demand declines, East & North remained stable. Rabi acreage is higher year-on-year, up by approximately 3% in wheat, oilseeds, and pulses as of January 2026, which is expected to support Q4 sell-out and early Kharif placement.

    03

    Segmental Growth and Product Mix

    The Crop Care segment grew by 18% to ₹580 crores in Q3 FY26, driven by volume expansion, new product promotion, and increased digital engagement. The Seeds business showed robust growth of 46% to ₹43 crores, benefiting from strong placements in paddy, mustard, and wheat. The Soil & Plant Health category also grew by 16% to ₹73 crores, with both price and volume growth, aided by successful in-house migration of biostimulant production. Domestic B2C revenue grew 13% to ₹391 crores, primarily from a 25% volume growth in fungicides for potato and cumin crops, though negative price impact was noted from liquidating near-expiry materials.

    04

    International Business and Global Competition

    Exports (B2B) topline surged by 73% to ₹129 crores, demonstrating promising growth due to volume expansion, customer base, and capacity utilization. The CSM segment also grew 26% to ₹46 crores. However, the global agrochemical market, valued at $75 billion in 2025 and projected to grow at a 5.5% CAGR, presents challenges. Pricing power remains limited due to intense global competition, with China's significant role as a primary supplier capping realizations and exposing costs to tariff and policy shifts, such as the upcoming VAT rebate discontinuation from April 2026.

    05

    Strategic Initiatives and Future Outlook

    Rallis India is focused on long-term value drivers including deepening customer-centricity, portfolio choices, and accelerating product launches. The company launched new products like 'Fateh Nxt' (herbicide) and 'NuCode' (biologicals platform) in 9M FY26. Digital initiatives like the 'Sampark Plus' app and the 'Idea2impact' open-innovation platform are aimed at enhancing demand creation and farmer engagement. Aspirationally, the company targets double-digit revenue growth and a 500 basis points expansion in overall blended margin over the next five years, primarily driven by operating leverage.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.